Bladder cancer imaging: An update

Current Opinion in Urology

Volumn 21, Issue 5, 2011, Pages 393-397

  Moses, Kelvin A ^a   Zhang, Jingbo ^a   Hricak, Hedvig ^a   Bochner, Bernard H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

18F FDG PET CT; bladder cancer; diffusion weighted MRI; multidetector computed tomography; staging

Indexed keywords

ACETIC ACID C 11; BCG VACCINE; ECHO CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER SCINTISCANNING; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; HUMAN; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; URINARY EXCRETION; UROGENITAL SCINTISCANNING; UROGRAPHY;

DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 80051711529     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32834956c3     Document Type: Review

References (20)

1. Karl A, Stepp H, Willmann E, et al. Optical coherence tomography for bladder cancer: ready as a surrogate for optical biopsy? Results of a prospective mono-centre study. Eur J Med Res 2010;15:131-134.
2. Schumacher MC, Holmang S, Davidsson T, et al. Transurethral resection of nonmuscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic acid under visible and fluorescent light: results of a prospective, randomised, multicentre study. Eur Urol 2010;57:293-299.
3. Nicolau C, Bunesch L, Peri L, et al. Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer. Br J Radiol 2010. [Epub ahead of print] This study in patients with known bladder tumors demonstrates the improved accuracy of contrast enhanced ultrasound when there are equivocal results in standard ultrasound studies.
4. Qu X, Huang X, Wu L, et al. Comparison of virtual cystoscopy and ultrasonography for bladder cancer detection: a meta-analysis. Eur J Radiol 2010. [Epub ahead of print]
5. Wang LJ, Wong YC, Ng KF, et al. Tumor characteristics of urothelial carcinoma on multidetector computerized tomography urography. J Urol 2010;183:2154-2160. This retrospective study in 70 patients undergoing evaluation for hematuria demonstrates the value of MDCT for bladder tumor staging.
6. Martingano P, Stacul F, Cavallaro M, et al. 64-Slice CT urography: 30 months of clinical experience. Radiol Med 2010;115:920-935.
7. El-Assmy A, Abou-El-Ghar ME, Mosbah A, et al. Bladder tumour staging: comparison of diffusion-and T2-weighted MR imaging. Eur Radiol 2009;19:1575-1581.
8. Takeuchi M, Sasaki S, Ito M, et al. Urinary bladder cancer: diffusion-weighted MR imaging: accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009;251:112-121.
9. Saokar A, Islam T, Jantsch M, et al. Detection of lymph nodes in pelvic malignancies with Computed Tomography and Magnetic Resonance Imaging. Clin Imaging 2010;34:361-366.
10. Thoeny HC, Triantafyllou M, Birkhaeuser FD, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009;55:761-769.
11. Bellin MF, Roy C. Magnetic resonance lymphography. Curr Opin Urol 2007;17:65-69. (Pubitemid 44901092)
12. Hoh CK, Schiepers C, Seltzer MA, et al. PET in oncology: will it replace the other modalities? Semin Nucl Med 1997;27:94-106. (Pubitemid 27194757)
13. Salminen E, Hogg A, Binns D, et al. Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice. Acta Oncol 2002;41:425-429. (Pubitemid 35222040)
14. Lodde M, Lacombe L, Friede J, et al. Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU Int 2010;106:658-663. This study demontrates the ability of FDG-PET/CT in detecting metastatic disease as well as improved sensitivity and specificity for detecting nodal disease.
15. Swinnen G, Maes A, Pottel H, et al. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 2010;57:641-647.
16. Jensen TK, Holt P, Gerke O, et al. Preoperative lymph-node staging of invasive urothelial bladder cancer with (18) F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: Correlation with histopathology. Scand J Urol Nephrol 2011;45:122-128.
17. Kibel AS, Dehdashti F, Katz MD, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 2009;27:4314-4320.
18. Schoder H, Ong SC, Reuter VE, et al. Initial results with (11) C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancer. Mol Imaging Biol 2011. [Epub ahead of print] This pilot study using 11C-acetate PET/CT for bladder cancer staging provides promising data that11C-acetate may be a useful alternative to 18F-FDG in patients who have not had prior BCG therapy.
19. Sadow CA, Wheeler SC, Kim J, et al. Positive predictive value of CT urography in the evaluation of upper tract urothelial cancer. AJR Am J Roentgenol 2010;195:W337-W343.
20. Sassi C, Santilli L, Concetti S, et al. Three-dimensional computed tomography of the orthotopic ileal neobladder reconstruction: normal and abnormal findings. Urol Int 2009;82:301-305.